Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Re-challenge of Anti-EGFR for Patients With RAS/BRAF Wild-type Metastatic CRC
ClinicalTrials.gov study NCT04224415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 I
ClinicalTrials.gov study NCT05607550. IPD Sharing: UNDECIDED. Countries: 19. Publications: 0.
Maintaining ERBB Blockade in EGFR-mutated Lung Cancer
ClinicalTrials.gov study NCT02488694. IPD Sharing: NO. Countries: 1. Publications: 0.
Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC
ClinicalTrials.gov study NCT02140333. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Antitumor Activity and Safety of BEBT-109, a Novel EGFR Inhibitor, in Previously Treated NSCLC
ClinicalTrials.gov study NCT06001671. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
ClinicalTrials.gov study NCT05948813. IPD Sharing: NO. Countries: 1. Publications: 0.
Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05800223. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs
ClinicalTrials.gov study NCT04519983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR).
ClinicalTrials.gov study NCT01717807. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30
ClinicalTrials.gov study NCT04598516. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer Patients
ClinicalTrials.gov study NCT03721289. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal Metastases
ClinicalTrials.gov study NCT06861218. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study
ClinicalTrials.gov study NCT01838577. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With
ClinicalTrials.gov study NCT07185997. IPD Sharing: UNDECIDED. Countries: 8. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-
ClinicalTrials.gov study NCT06829459. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR
ClinicalTrials.gov study NCT03940131. IPD Sharing: NO. Countries: 1. Publications: 0.
Vebreltinib Plus PLB1004 in EGFR-mutated, Advanced NSCLC With MET Amplification or MET Overexpression Following EGFR-TKI
ClinicalTrials.gov study NCT06343064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02775006. IPD Sharing: NO. Countries: 1. Publications: 0.
PANORAMA - Real World Molecular Testing, Treatment Patterns, and Clinical Outcomes EGFR Mutation-Positive NSCLC
ClinicalTrials.gov study NCT02777658. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, P
ClinicalTrials.gov study NCT06728865. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.